CYTOKINETICS INC 4
4 · CYTOKINETICS INC · Filed Sep 5, 2013
Insider Transaction Report
Form 4
CYTOKINETICS INCCYTK
WOLFF ANDREW A
SVP Clinical R&D, CMO
Transactions
- Exercise/Conversion
Restricted Stock Units
2013-09-03−14,583→ 0 total→ Common Stock (14,583 underlying) - Exercise/Conversion
Common Stock
2013-09-03+14,583→ 26,116 total - Tax Payment
Common Stock
2013-09-03$7.65/sh−5,479$41,914→ 20,637 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of CYTK common stock at a purchase price of $0.001 per share which is the current par value of the common stock.
- [F2]Shares withheld by Issuer to cover taxes associated with settlement of Restricted Stock Units
- [F3]The restricted stock units vest in two equal annual installments. Vested shares will be delivered to the reporting person on 9/4/2012 and 9/3/2013.